These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32410218)

  • 41. The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations.
    Ashrafzadeh S; Nambudiri VE
    J Am Acad Dermatol; 2020 Jul; 83(1):e83-e84. PubMed ID: 32380217
    [No Abstract]   [Full Text] [Related]  

  • 42. Trends in teledermatology use during clinic reopening after COVID-19 closures.
    Su MY; Smith GP; Das S
    J Am Acad Dermatol; 2021 Apr; 84(4):e213-e214. PubMed ID: 33316330
    [No Abstract]   [Full Text] [Related]  

  • 43. Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?
    Shanshal M
    J Drugs Dermatol; 2020 Apr; 19(4):436. PubMed ID: 32401460
    [No Abstract]   [Full Text] [Related]  

  • 44. Coronavirus-days ın dermatology.
    Türsen Ü; Türsen B; Lotti T
    Dermatol Ther; 2020 Jul; 33(4):e13438. PubMed ID: 32307810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Teledermatology with general practitioners and pediatricians during COVID-19 outbreak in Italy: Preliminary data from a second-level dermatology department in North-Eastern Italy.
    Bergamo S; Calacione R; Fagotti S; Finizio L; Scaini M; Schiesari L; Gatti A
    Dermatol Ther; 2020 Nov; 33(6):e14040. PubMed ID: 32696492
    [No Abstract]   [Full Text] [Related]  

  • 46. Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256".
    Potestio L; Villani A; Raia F; Fabbrocini G; Martora F
    J Cosmet Dermatol; 2023 Mar; 22(3):1134-1135. PubMed ID: 36700374
    [No Abstract]   [Full Text] [Related]  

  • 47. [What can we learn from the COVID-19 pandemic in general and about ourselves as dermatologists?].
    Kluger N
    Ann Dermatol Venereol; 2020; 147(6-7):413-417. PubMed ID: 32414508
    [No Abstract]   [Full Text] [Related]  

  • 48. Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances.
    Reinholz M; French LE
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):e214-e216. PubMed ID: 32219888
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term results of teledermatology for acne patients during COVID-19 pandemic.
    Villani A; Annunziata MC; Megna M; Scalvenzi M; Fabbrocini G
    J Cosmet Dermatol; 2022 Apr; 21(4):1356-1357. PubMed ID: 35090188
    [No Abstract]   [Full Text] [Related]  

  • 50. Asynchronous direct to patient teledermatology visits (e-visits) during COVID-19 pandemic: Lessons for future teledermatology practice.
    Trupiano N; Goldberg RH; Novice M; Mai J; Zhang H; Renati S; Castanedo-Tardan MP; Tejasvi T
    J Am Acad Dermatol; 2024 May; 90(5):1037-1039. PubMed ID: 38246561
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of COVID-19 outbreak on dermatology services: Dermatology in isolation.
    Damevska K; Neloska L; Simeonovski V; Petrov A; Dimitrovska I; Teovska-Mitrevska N; Najdova A; Pollozhani N
    Dermatol Ther; 2020 Jul; 33(4):e13552. PubMed ID: 32390176
    [No Abstract]   [Full Text] [Related]  

  • 52. Unpredicted Disasters Such as Coronavirus Disease (COVID-19) Highlight the Importance of Teledermatology.
    Seyed Jafari SM; Hunger RE
    Dermatology; 2021; 237(1):15-16. PubMed ID: 33316805
    [No Abstract]   [Full Text] [Related]  

  • 53. COVID-19: Challenges and opportunities for dermatology response.
    Chawla S
    J Dermatolog Treat; 2020 Jun; 31(4):326. PubMed ID: 32241193
    [No Abstract]   [Full Text] [Related]  

  • 54. Direct-to-Consumer Teledermatology Growth: A Review and Outlook for the Future.
    Ranpariya V; Kats D; Lipoff JB
    Cutis; 2022 Apr; 109(4):211-217. PubMed ID: 35659836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Supporting Virtual Dermatology Consultation in the Setting of COVID-19.
    Kutner A; Love D; Markova A; Rossi A; Lee E; Nehal K; Lacouture M; Rotemberg V
    J Digit Imaging; 2021 Apr; 34(2):284-289. PubMed ID: 33689061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing education for dermatology residents during the COVID-19 pandemic.
    Patel P; Guzman AK; McLellan B; Blasiak R
    J Am Acad Dermatol; 2020 Oct; 83(4):e319-e320. PubMed ID: 32682029
    [No Abstract]   [Full Text] [Related]  

  • 57. Barriers and facilitators to mobile health and active surveillance use among older adults with skin disease.
    Johnson A; Shukla N; Halley M; Nava V; Budaraju J; Zhang L; Linos E
    Health Expect; 2021 Oct; 24(5):1582-1592. PubMed ID: 34190397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Teledermatology in the wake of COVID-19: Advantages and challenges to continued care in a time of disarray.
    Gupta R; Ibraheim MK; Doan HQ
    J Am Acad Dermatol; 2020 Jul; 83(1):168-169. PubMed ID: 32334056
    [No Abstract]   [Full Text] [Related]  

  • 59. Teledermatology: a useful tool to fight COVID-19.
    Villani A; Scalvenzi M; Fabbrocini G
    J Dermatolog Treat; 2020 Jun; 31(4):325. PubMed ID: 32238000
    [No Abstract]   [Full Text] [Related]  

  • 60. Guiding principles for prioritization of limited in-person dermatology appointments during the COVID-19 pandemic.
    Stoff BK; Blalock TW; Swerlick RA; MacKelfresh JB; Lawley LP; Chen SC
    J Am Acad Dermatol; 2020 Oct; 83(4):1228-1230. PubMed ID: 32682028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.